Weekly IPO Recap – Investors Strong Appetite for Blue Buffalo

This past week three IPOs debuted, seven updated terms and two new deals filed.

Of the three deals that debuted, Blue Buffalo Pet Products (Nasdaq: BUFF) opened with the most strength. After upsizing and pricing above range ($20.00), ‘BUFF’ opened with a 35% premium with a $27.00 first trade. The deal traded as high as $28.31 before closing the week at $26.80. Neos Therapeutics (Nasdaq: NEOS) priced at the mid-point of the range, $15.00, and opened with an impressive $3.22 premium—good for a 21% return above the offering price. Live Oak Bancshares (Nasdaq: LOB) also priced at the mid-point of its range, $17.00, and opened with a $1.50 boost above the offering price. ‘LOB’ hit a first week high of $20.35 for a 20% gain at top-tick.

(Click to Expand)

It should be noted that a deal that was expected to debut this past week, ETRE REIT (Nasdaq: ESSF), was postponed due to market conditions. This was the second time this IPO has been postponed and there is no further information at this time.

Looking ahead to this week, there are seven deals on the schedule and we are hearing early, positive street chatter about…

SUBSCRIPTION NEEDED

IPO Schedule – Week of July 27

Please check your emails early and often. We may upgrade or downgrade an IPO and or secondary –sometimes with not as much notice as we would like to give. If you have interest in IPOs do NOT delay your IOI’s (hopefully they are already in)…you can always cancel them. We will keep you posted if and as when…we have anything pertinent to add. The current number of “active” IPOs in the pipeline as of 7/24/15 is 133.  Good luck trading!